市場調査レポート

商品コード

1525476

神経血管デバイスの世界市場の評価：製品別、用途別、サイズ別、エンドユーザー別、地域別、機会、予測、2017年～2031年

Neurovascular Devices Market Assessment, By Product, By Application, By Size, By End-user, By Region, Opportunities and Forecast, 2017-2031F

出版日: 2024年08月02日
発行: Market Xcel - Markets and Data
ページ情報: 英文 232 Pages
納期: 3～5営業日

カスタマイズ可能

価格

PDF & Excel Printable (Single User License)

USD 4,800 708,000円

レポートPDFを1名の方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Corporate License)

USD 6,000 885,000円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能ですが、企業内部での利用に限定されます。ご利用に際しては、あらかじめ出版社の許諾を得る必要があります。詳細はお問合せください。印刷は可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Custom Research License)

USD 8,500 1,253,750円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。アナリストアワー100時間が含まれており、レポートのカスタマイズなどにご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=147.50円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の神経血管デバイスの市場規模は、予測期間の2024年～2031年に7.80%のCAGRで拡大し、2023年の33億5,000万米ドルから2031年には61億1,000万米ドルに成長すると予測されています。神経血管デバイス市場は医療機器産業の重要な一部であり、医療機器産業の中でも最も速い成長率を占めています。神経疾患の有病率の上昇、低侵襲手術の採用率の上昇、技術の進歩などの要因が市場を牽引しています。

脳動静脈奇形（AVM）と脳動脈瘤は、神経血管デバイスで治療される脳の血管異常の2つの例です。脳塞栓術と動脈瘤コイリング術は神経血管器具の2つの重要なカテゴリーです。ポケットを満たし血流を阻害することで、これらの極小ワイヤーをコイル状にして動脈瘤に留置します。2023年には、塞栓コイルが脳動脈瘤の治療に最も多く使用されました。脳血管形成術およびステント留置システムは、脳の閉塞または制限された動脈の詰まりを取り除くために使用され、神経血管デバイスの重要な一部です。これらの装置には、動脈を開いた状態に保つために留置するステントと、動脈を拡大するために膨らませるバルーンカテーテルがあります。急性虚血性脳卒中では、神経血栓除去装置を用いて脳の閉塞動脈から血栓を除去します。ステントリトリーバーと吸引カテーテルがその2つの例です。経橈骨動脈アクセス装置では、鼠径部の大腿動脈を使う代わりに、手首の橈骨動脈を使って脳の動脈にアクセスします。この方法は患者の回復期間を短縮し、問題を最小限に抑えます。

神経血管疾患の有病率の上昇は、神経血管医療機器の需要を煽る主な要因です。CDCのデータによると、脳卒中になる確率は55歳以降10年ごとに倍増します。高齢化、喫煙、肥満、高血圧などの要因により、神経血管疾患の世界的発生率は増加傾向にあります。このような神経疾患の診断、モニタリング、治療を改善するために、神経血管デバイスや介入型治療法の採用が、神経血管疾患をターゲットとする患者基盤の大きさと急速な拡大によって大いに助けられています。世界脳卒中ファクトシートのデータによると、約1億100万人が脳卒中を経験しています。15歳から49歳は、脳卒中経験者で生存している人の22％を占めています。

当レポートでは、世界の神経血管デバイス市場について調査し、市場の概要とともに、製品別、用途別、サイズ別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

List of Tables

Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

Figure 1. Global Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
Figure 2. Global Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
Figure 3. Global Neurovascular Devices Market Share (%), By Product, 2017-2031F
Figure 4. Global Neurovascular Devices Market Share (%), By Application, 2017-2031F
Figure 5. Global Neurovascular Devices Market Share (%), By Size, 2017-2031F
Figure 6. Global Neurovascular Devices Market Share (%), By End-user, 2017-2031F
Figure 7. Global Neurovascular Devices Market Share (%), By Region, 2017-2031F
Figure 8. North America Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
Figure 9. North America Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
Figure 10. North America Neurovascular Devices Market Share (%), By Product, 2017-2031F
Figure 11. North America Neurovascular Devices Market Share (%), By Application, 2017-2031F
Figure 12. North America Neurovascular Devices Market Share (%), By Size, 2017-2031F
Figure 13. North America Neurovascular Devices Market Share (%), By End-user, 2017-2031F
Figure 14. North America Neurovascular Devices Market Share (%), By Country, 2017-2031F
Figure 15. United States Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
Figure 16. United States Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
Figure 17. United States Neurovascular Devices Market Share (%), By Product, 2017-2031F
Figure 18. United States Neurovascular Devices Market Share (%), By Application, 2017-2031F
Figure 19. United States Neurovascular Devices Market Share (%), By Size, 2017-2031F
Figure 20. United States Neurovascular Devices Market Share (%), By End-user, 2017-2031F
Figure 21. Canada Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
Figure 22. Canada Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
Figure 23. Canada Neurovascular Devices Market Share (%), By Product, 2017-2031F
Figure 24. Canada Neurovascular Devices Market Share (%), By Application, 2017-2031F
Figure 25. Canada Neurovascular Devices Market Share (%), By Size, 2017-2031F
Figure 26. Canada Neurovascular Devices Market Share (%), By End-user, 2017-2031F
Figure 27. Mexico Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
Figure 28. Mexico Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
Figure 29. Mexico Neurovascular Devices Market Share (%), By Product, 2017-2031F
Figure 30. Mexico Neurovascular Devices Market Share (%), By Application, 2017-2031F
Figure 31. Mexico Neurovascular Devices Market Share (%), By Size, 2017-2031F
Figure 32. Mexico Neurovascular Devices Market Share (%), By End-user, 2017-2031F
Figure 33. Europe Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
Figure 34. Europe Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
Figure 35. Europe Neurovascular Devices Market Share (%), By Product, 2017-2031F
Figure 36. Europe Neurovascular Devices Market Share (%), By Application, 2017-2031F
Figure 37. Europe Neurovascular Devices Market Share (%), By Size, 2017-2031F
Figure 38. Europe Neurovascular Devices Market Share (%), By End-user, 2017-2031F
Figure 39. Europe Neurovascular Devices Market Share (%), By Country, 2017-2031F
Figure 40. Germany Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
Figure 41. Germany Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
Figure 42. Germany Neurovascular Devices Market Share (%), By Product, 2017-2031F
Figure 43. Germany Neurovascular Devices Market Share (%), By Application, 2017-2031F
Figure 44. Germany Neurovascular Devices Market Share (%), By Size, 2017-2031F
Figure 45. Germany Neurovascular Devices Market Share (%), By End-user, 2017-2031F
Figure 46. France Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
Figure 47. France Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
Figure 48. France Neurovascular Devices Market Share (%), By Product, 2017-2031F
Figure 49. France Neurovascular Devices Market Share (%), By Application, 2017-2031F
Figure 50. France Neurovascular Devices Market Share (%), By Size, 2017-2031F
Figure 51. France Neurovascular Devices Market Share (%), By End-user, 2017-2031F
Figure 52. Italy Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
Figure 53. Italy Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
Figure 54. Italy Neurovascular Devices Market Share (%), By Product, 2017-2031F
Figure 55. Italy Neurovascular Devices Market Share (%), By Application, 2017-2031F
Figure 56. Italy Neurovascular Devices Market Share (%), By Size, 2017-2031F
Figure 57. Italy Neurovascular Devices Market Share (%), By End-user, 2017-2031F
Figure 58. United Kingdom Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
Figure 59. United Kingdom Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
Figure 60. United Kingdom Neurovascular Devices Market Share (%), By Product, 2017-2031F
Figure 61. United Kingdom Neurovascular Devices Market Share (%), By Application, 2017-2031F
Figure 62. United Kingdom Neurovascular Devices Market Share (%), By Size, 2017-2031F
Figure 63. United Kingdom Neurovascular Devices Market Share (%), By End-user, 2017-2031F
Figure 64. Russia Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
Figure 65. Russia Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
Figure 66. Russia Neurovascular Devices Market Share (%), By Product, 2017-2031F
Figure 67. Russia Neurovascular Devices Market Share (%), By Application, 2017-2031F
Figure 68. Russia Neurovascular Devices Market Share (%), By Size, 2017-2031F
Figure 69. Russia Neurovascular Devices Market Share (%), By End-user, 2017-2031F
Figure 70. Netherlands Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
Figure 71. Netherlands Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
Figure 72. Netherlands Neurovascular Devices Market Share (%), By Product, 2017-2031F
Figure 73. Netherlands Neurovascular Devices Market Share (%), By Application, 2017-2031F
Figure 74. Netherlands Neurovascular Devices Market Share (%), By Size, 2017-2031F
Figure 75. Netherlands Neurovascular Devices Market Share (%), By End-user, 2017-2031F
Figure 76. Spain Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
Figure 77. Spain Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
Figure 78. Spain Neurovascular Devices Market Share (%), By Product, 2017-2031F
Figure 79. Spain Neurovascular Devices Market Share (%), By Application, 2017-2031F
Figure 80. Spain Neurovascular Devices Market Share (%), By Size, 2017-2031F
Figure 81. Spain Neurovascular Devices Market Share (%), By End-user, 2017-2031F
Figure 82. Turkey Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
Figure 83. Turkey Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
Figure 84. Turkey Neurovascular Devices Market Share (%), By Product, 2017-2031F
Figure 85. Turkey Neurovascular Devices Market Share (%), By Application, 2017-2031F
Figure 86. Turkey Neurovascular Devices Market Share (%), By Size, 2017-2031F
Figure 87. Turkey Neurovascular Devices Market Share (%), By End-user, 2017-2031F
Figure 88. Poland Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
Figure 89. Poland Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
Figure 90. Poland Neurovascular Devices Market Share (%), By Product, 2017-2031F
Figure 91. Poland Neurovascular Devices Market Share (%), By Application, 2017-2031F
Figure 92. Poland Neurovascular Devices Market Share (%), By Size, 2017-2031F
Figure 93. Poland Neurovascular Devices Market Share (%), By End-user, 2017-2031F
Figure 94. South America Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
Figure 95. South America Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
Figure 96. South America Neurovascular Devices Market Share (%), By Product, 2017-2031F
Figure 97. South America Neurovascular Devices Market Share (%), By Application, 2017-2031F
Figure 98. South America Neurovascular Devices Market Share (%), By Size, 2017-2031F
Figure 99. South America Neurovascular Devices Market Share (%), By End-user, 2017-2031F
Figure 100. South America Neurovascular Devices Market Share (%), By Country, 2017-2031F
Figure 101. Brazil Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
Figure 102. Brazil Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
Figure 103. Brazil Neurovascular Devices Market Share (%), By Product, 2017-2031F
Figure 104. Brazil Neurovascular Devices Market Share (%), By Application, 2017-2031F
Figure 105. Brazil Neurovascular Devices Market Share (%), By Size, 2017-2031F
Figure 106. Brazil Neurovascular Devices Market Share (%), By End-user, 2017-2031F
Figure 107. Argentina Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
Figure 108. Argentina Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
Figure 109. Argentina Neurovascular Devices Market Share (%), By Product, 2017-2031F
Figure 110. Argentina Neurovascular Devices Market Share (%), By Application, 2017-2031F
Figure 111. Argentina Neurovascular Devices Market Share (%), By Size, 2017-2031F
Figure 112. Argentina Neurovascular Devices Market Share (%), By End-user, 2017-2031F
Figure 113. Asia-Pacific Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
Figure 114. Asia-Pacific Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
Figure 115. Asia-Pacific Neurovascular Devices Market Share (%), By Product, 2017-2031F
Figure 116. Asia-Pacific Neurovascular Devices Market Share (%), By Application, 2017-2031F
Figure 117. Asia-Pacific Neurovascular Devices Market Share (%), By Size, 2017-2031F
Figure 118. Asia-Pacific Neurovascular Devices Market Share (%), By End-user, 2017-2031F
Figure 119. Asia-Pacific Neurovascular Devices Market Share (%), By Country, 2017-2031F
Figure 120. India Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
Figure 121. India Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
Figure 122. India Neurovascular Devices Market Share (%), By Product, 2017-2031F
Figure 123. India Neurovascular Devices Market Share (%), By Application, 2017-2031F
Figure 124. India Neurovascular Devices Market Share (%), By Size, 2017-2031F
Figure 125. India Neurovascular Devices Market Share (%), By End-user, 2017-2031F
Figure 126. China Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
Figure 127. China Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
Figure 128. China Neurovascular Devices Market Share (%), By Product, 2017-2031F
Figure 129. China Neurovascular Devices Market Share (%), By Application, 2017-2031F
Figure 130. China Neurovascular Devices Market Share (%), By Size, 2017-2031F
Figure 131. China Neurovascular Devices Market Share (%), By End-user, 2017-2031F
Figure 132. Japan Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
Figure 133. Japan Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
Figure 134. Japan Neurovascular Devices Market Share (%), By Product, 2017-2031F
Figure 135. Japan Neurovascular Devices Market Share (%), By Application, 2017-2031F
Figure 136. Japan Neurovascular Devices Market Share (%), By Size, 2017-2031F
Figure 137. Japan Neurovascular Devices Market Share (%), By End-user, 2017-2031F
Figure 138. Australia Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
Figure 139. Australia Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
Figure 140. Australia Neurovascular Devices Market Share (%), By Product, 2017-2031F
Figure 141. Australia Neurovascular Devices Market Share (%), By Application, 2017-2031F
Figure 142. Australia Neurovascular Devices Market Share (%), By Size, 2017-2031F
Figure 143. Australia Neurovascular Devices Market Share (%), By End-user, 2017-2031F
Figure 144. Vietnam Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
Figure 145. Vietnam Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
Figure 146. Vietnam Neurovascular Devices Market Share (%), By Product, 2017-2031F
Figure 147. Vietnam Neurovascular Devices Market Share (%), By Application, 2017-2031F
Figure 148. Vietnam Neurovascular Devices Market Share (%), By Size, 2017-2031F
Figure 149. Vietnam Neurovascular Devices Market Share (%), By End-user, 2017-2031F
Figure 150. South Korea Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
Figure 151. South Korea Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
Figure 152. South Korea Neurovascular Devices Market Share (%), By Product, 2017-2031F
Figure 153. South Korea Neurovascular Devices Market Share (%), By Application, 2017-2031F
Figure 154. South Korea Neurovascular Devices Market Share (%), By Size, 2017-2031F
Figure 155. South Korea Neurovascular Devices Market Share (%), By End-user, 2017-2031F
Figure 156. Indonesia Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
Figure 157. Indonesia Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
Figure 158. Indonesia Neurovascular Devices Market Share (%), By Product, 2017-2031F
Figure 159. Indonesia Neurovascular Devices Market Share (%), By Application, 2017-2031F
Figure 160. Indonesia Neurovascular Devices Market Share (%), By Size, 2017-2031F
Figure 161. Indonesia Neurovascular Devices Market Share (%), By End-user, 2017-2031F
Figure 162. Philippines Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
Figure 163. Philippines Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
Figure 164. Philippines Neurovascular Devices Market Share (%), By Product, 2017-2031F
Figure 165. Philippines Neurovascular Devices Market Share (%), By Application, 2017-2031F
Figure 166. Philippines Neurovascular Devices Market Share (%), By Size, 2017-2031F
Figure 167. Philippines Neurovascular Devices Market Share (%), By End-user, 2017-2031F
Figure 168. Middle East & Africa Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
Figure 169. Middle East & Africa Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
Figure 170. Middle East & Africa Neurovascular Devices Market Share (%), By Product, 2017-2031F
Figure 171. Middle East & Africa Neurovascular Devices Market Share (%), By Application, 2017-2031F
Figure 172. Middle East & Africa Neurovascular Devices Market Share (%), By Size, 2017-2031F
Figure 173. Middle East & Africa Neurovascular Devices Market Share (%), By End-user, 2017-2031F
Figure 174. Middle East & Africa Neurovascular Devices Market Share (%), By Country, 2017-2031F
Figure 175. Saudi Arabia Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
Figure 176. Saudi Arabia Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
Figure 177. Saudi Arabia Neurovascular Devices Market Share (%), By Product, 2017-2031F
Figure 178. Saudi Arabia Neurovascular Devices Market Share (%), By Application, 2017-2031F
Figure 179. Saudi Arabia Neurovascular Devices Market Share (%), By Size, 2017-2031F
Figure 180. Saudi Arabia Neurovascular Devices Market Share (%), By End-user, 2017-2031F
Figure 181. UAE Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
Figure 182. UAE Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
Figure 183. UAE Neurovascular Devices Market Share (%), By Product, 2017-2031F
Figure 184. UAE Neurovascular Devices Market Share (%), By Application, 2017-2031F
Figure 185. UAE Neurovascular Devices Market Share (%), By Size, 2017-2031F
Figure 186. UAE Neurovascular Devices Market Share (%), By End-user, 2017-2031F
Figure 187. South Africa Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
Figure 188. South Africa Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
Figure 189. South Africa Neurovascular Devices Market Share (%), By Product, 2017-2031F
Figure 190. South Africa Neurovascular Devices Market Share (%), By Application, 2017-2031F
Figure 191. South Africa Neurovascular Devices Market Share (%), By Size, 2017-2031F
Figure 192. South Africa Neurovascular Devices Market Share (%), By End-user, 2017-2031F
Figure 193. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 194. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 195. By Size Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 196. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 197. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

Product Code: MX11697

Global neurovascular devices market is projected to witness a CAGR of 7.80% during the forecast period 2024-2031, growing from USD 3.35 billion in 2023 to USD 6.11 billion in 2031. The neurovascular devices market is an important part of the medical device industry, accounting for one of the fastest growth rates in the medical device industry. Factors are driving the market such as increasing prevalence of neurological disorders, rising adoption of minimally invasive surgeries, and technological advancements.

Arteriovenous malformations (AVMs) and cerebral aneurysms are two instances of blood vessel abnormalities in the brain that are treated with neurovascular devices. Cerebral embolization and aneurysm coiling devices are two important categories of neurovascular devices. By filling the pocket and obstructing blood flow, these tiny wires are coiled and placed into the aneurysm. In 2023, embolization coils were used the most for treating brain aneurysms. Cerebral angioplasty and stenting systems, which are used to unblock blocked or restricted arteries in the brain are an important part of neurovascular devices. These devices include stents, which are placed to keep the artery open, and balloon catheters, which are inflated to enlarge the artery. During an acute ischemic stroke, blood clots are removed from blocked arteries in the brain using neurothrombectomy devices. Stent retrievers and aspiration catheters are two instances of these devices. Instead of using the femoral artery in the groin, transradial access devices use the radial artery in the wrist to access the brain's arteries. This method reduces the patient's recovery period and minimizes problems.

In June 2024, Medtronic announced the launch of Artisse intrasaccular device for treating intercranial aneurysms. The launch took place at the same time when preliminary data about the device's performance, safety, and efficacy were made public for the first time at LINNC Paris 2024. Artisse was developed to meet the demands of patients with complicated wide-neck bifurcation aneurysms that were previously treated with intrasaccular basket devices, coil adjunctive neck-bridging devices, and stent-assisted coiling.

Increasing Prevalence of Neurovascular Diseases

The growing prevalence of neurovascular diseases is a key driver fueling the demand for neurovascular medical devices. According to CDC data, the chance of a stroke doubles every ten years after turning 55 years old. The global incidence of neurovascular illness is on the rise due to factors such as the aging population, smoking, obesity, and high blood pressure. To improve diagnosis, monitoring, and treatment of these neurological diseases, the adoption of neurovascular devices and interventional therapeutic procedures is being greatly aided by the sizeable and quickly expanding patient base for targeting neurovascular diseases. According to data from the global stroke fact sheet, approximately 101 million individuals have experienced stroke. 15 to 49-year-olds make up 22% of those who have had a stroke and are still alive.

Technological Advancements to Evolve Neurovascular Devices Market

Innovations in the medical device industry are associated with the development of novel methods, procedures, or technology for the diagnosis, treatment, and management of illness in response to the need for improved patient outcomes and lower healthcare expenses. Medical device companies are continuing to innovate in the neurovascular device industry, concentrating their research and development efforts on advanced technologies that have the potential to enhance outcomes and support the growth of the ischemic and hemorrhagic stroke devices. SmartTRAK identified emerging technologies that could potentially disrupt the neurovascular devices market over the next two to five years in two recent neurointerventional meetings, the 14th European Society for Minimally Invasive Neurological Therapy (ESMINT) Congress 2022 and the 19th Annual Meeting of the Society for NeuroInterventional Surgery (SNIS). It includes new methods of aspiration for the treatment of acute ischemic stroke (AIS), novel intrasaccular flow interruption devices, and supporting technology for neurointerventional treatments.

Cerebral Embolization and Aneurysm Coiling Devices Dominate the Global Neurovascular Devices Market

Cerebral embolization and aneurysm coiling devices dominate the global neurovascular devices market. Brain aneurysms that were previously thought to be incurable can be treated using minimally invasive coil embolization. Compared to open surgery, this approach for the treatment of aneurysms is less invasive and needs a considerably shorter recovery period. Better outcomes can be achieved from coil embolization of small aneurysms with narrow necks than from embolization of big or enormous aneurysms with broad necks. Over 80% of aneurysms treated with coil embolization have proven permanent success in the long term. In August 2023, Microport Neurotech received marketing approval for numen coil embolization system. Numen is categorized as a Category IV high-risk medical device, implying that registering it requires a high level of expertise. The Japanese authorities have approved this neurointerventional device, highlighting its innovative clinical design and excellent performance.

Asia-Pacific is Expected to Grow at the Fastest Rate in the Forecast Period

Asia-Pacific is anticipated to witness a significant growth in the demand for neurovascular devices in the forecast period. The primary drivers for the growth of neurovascular devices in Asia-Pacific are the rising prevalence of neurovascular diseases, growth in adoption of minimally invasive surgeries and geriatric population. Neurovascular diseases that may impact the blood artery network around the brain, results in ailments such as aneurysms and strokes that are treated with neurovascular devices. Increasing awareness of neurovascular procedures and a sizable patient base due to neurovascular illnesses are crucial reasons driving the market expansion in Asia-Pacific. In India, stroke is the second most prevalent cause of death. India encounters about 1,85,000 strokes annually, with one stroke occurring roughly every forty seconds and related mortality occurring every four minutes.

Future Market Scenario (2024-2031F)

The future of neurovascular devices looks promising, driven by advancements in technology and the growing prevalence of neurovascular conditions. Cerebral embolization and aneurysm coiling devices are expected to remain a key focus area, as these thin wire coils that fill and block blood flow to aneurysms continue to be the most preferred treatment methods. Cerebral angioplasty and stenting systems are poised for growth, as they are used to open narrowed or blocked arteries in the brain. Innovations in these devices, such as the development of flow diversion stents, are allowing for more precise and controlled placement during procedures.

Key Players Landscape and Outlook

Several medical device companies are flourishing in the neurovascular devices market by planning and adopting new strategies. They are complying with new strategic initiatives for neurovascular devices to increase their market presence. New agreements, contracts, acquisitions mergers, investments, and partnerships are major ways through which the market players are trying to achieve higher market share.

EndoStream Medical announced in February 2023, that the first patient was enrolled in the US clinical study for its Nautilus intrasaccular system. The goal of the TORNADO-US clinical research project was to evaluate the Nautilus Intrasaccular System, an innovative device for treating brain aneurysms. The patient was treated in New York at The Mount Sinai Hospital. In addition, Kaneka i-ED coils were utilized in conjunction with the Nautilus Intrasaccular System to treat the patient.

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Neurovascular Devices Market Outlook, 2017-2031F

4.1. Market Size & Forecast
- 4.1.1. By Value
- 4.1.2. By Volume
4.2. By Product
- 4.2.1. Cerebral Embolization and Aneurysm Coiling Devices
  - 4.2.1.1. Embolic Coils
  - 4.2.1.2. Flow Diversion Devices
  - 4.2.1.3. Liquid Embolic Agents
- 4.2.2. Cerebral Angioplasty and Stenting Systems
  - 4.2.2.1. Carotid Artery Stents
  - 4.2.2.2. Embolic Protection
- 4.2.3. Neurothrombectomy Devices
  - 4.2.3.1. Clot Retrieval Devices
  - 4.2.3.2. Suction Devices/Aspiration Catheters
  - 4.2.3.3. Vascular Snares
- 4.2.4. Support Devices
  - 4.2.4.1. Micro Catheters
  - 4.2.4.2. Micro Guidewires
- 4.2.5. Trans Radial Access Devices
4.3. By Application
- 4.3.1. Cerebral Aneurysm
- 4.3.2. Ischemic Stroke
- 4.3.3. Carotid Artery Stenosis
- 4.3.4. Arteriovenous Malformation and Fistulas
- 4.3.5. Others
4.4. By Size
- 4.4.1. 0.027 inches
- 4.4.2. 0.021 inches
- 4.4.3. 0.071 inches
- 4.4.4. 0.017 inches
- 4.4.5. Others
4.5. By End-user
- 4.5.1. Hospitals
- 4.5.2. Ambulatory Surgical Centers
- 4.5.3. Others
4.6. By Region
- 4.6.1. North America
- 4.6.2. Europe
- 4.6.3. Asia-Pacific
- 4.6.4. South America
- 4.6.5. Middle East and Africa
4.7. By Company Market Share (%), 2023

5. Global Neurovascular Devices Market Outlook, By Region, 2017-2031F

5.1. North America*
- 5.1.1. Market Size & Forecast
  - 5.1.1.1. By Value
  - 5.1.1.2. By Volume
- 5.1.2. By Product
  - 5.1.2.1. Cerebral Embolization and Aneurysm Coiling Devices
    - 5.1.2.1.1. Embolic Coils
    - 5.1.2.1.2. Flow Diversion Devices
    - 5.1.2.1.3. Liquid Embolic Agents
  - 5.1.2.2. Cerebral Angioplasty and Stenting Systems
    - 5.1.2.2.1. Carotid Artery Stents
    - 5.1.2.2.2. Embolic Protection
  - 5.1.2.3. Neurothrombectomy Devices
    - 5.1.2.3.1. Clot Retrieval Devices
    - 5.1.2.3.2. Suction Devices/Aspiration Catheters
    - 5.1.2.3.3. Vascular Snares
  - 5.1.2.4. Support Devices
    - 5.1.2.4.1. Micro Catheters
    - 5.1.2.4.2. Micro Guidewires
  - 5.1.2.5. Trans Radial Access Devices
- 5.1.3. By Application
  - 5.1.3.1. Cerebral Aneurysm
  - 5.1.3.2. Ischemic Stroke
  - 5.1.3.3. Carotid Artery Stenosis
  - 5.1.3.4. Arteriovenous Malformation and Fistulas
  - 5.1.3.5. Others
- 5.1.4. By Size
  - 5.1.4.1. 0.027 inches
  - 5.1.4.2. 0.021 inches
  - 5.1.4.3. 0.071 inches
  - 5.1.4.4. 0.017 inches
  - 5.1.4.5. Others
- 5.1.5. By End-user
  - 5.1.5.1. Hospitals
  - 5.1.5.2. Ambulatory Surgical Centers
  - 5.1.5.3. Others
- 5.1.6. United States*
  - 5.1.6.1. Market Size & Forecast
    - 5.1.6.1.1. By Value
    - 5.1.6.1.2. By Volume
  - 5.1.6.2. By Product
    - 5.1.6.2.1. Cerebral Embolization and Aneurysm Coiling Devices
      - 5.1.6.2.1.1. Embolic Coils
      - 5.1.6.2.1.2. Flow Diversion Devices
      - 5.1.6.2.1.3. Liquid Embolic Agents
    - 5.1.6.2.2. Cerebral Angioplasty and Stenting Systems
      - 5.1.6.2.2.1. Carotid Artery Stents
      - 5.1.6.2.2.2. Embolic Protection
    - 5.1.6.2.3. Neurothrombectomy Devices
      - 5.1.6.2.3.1. Clot Retrieval Devices
      - 5.1.6.2.3.2. Suction Devices/Aspiration Catheters
      - 5.1.6.2.3.3. Vascular Snares
    - 5.1.6.2.4. Support Devices
      - 5.1.6.2.4.1. Micro Catheters
      - 5.1.6.2.4.2. Micro Guidewires
    - 5.1.6.2.5. Trans Radial Access Devices
  - 5.1.6.3. By Application
    - 5.1.6.3.1. Cerebral Aneurysm
    - 5.1.6.3.2. Ischemic Stroke
    - 5.1.6.3.3. Carotid Artery Stenosis
    - 5.1.6.3.4. Arteriovenous Malformation and Fistulas
    - 5.1.6.3.5. Others
  - 5.1.6.4. By Size
    - 5.1.6.4.1. 0.027 inches
    - 5.1.6.4.2. 0.021 inches
    - 5.1.6.4.3. 0.071 inches
    - 5.1.6.4.4. 0.017 inches
    - 5.1.6.4.5. Others
  - 5.1.6.5. By End-user
    - 5.1.6.5.1. Hospitals
    - 5.1.6.5.2. Ambulatory Surgical Centers
    - 5.1.6.5.3. Others
- 5.1.7. Canada
- 5.1.8. Mexico

All segments will be provided for all regions and countries covered

5.2. Europe
- 5.2.1. Germany
- 5.2.2. France
- 5.2.3. Italy
- 5.2.4. United Kingdom
- 5.2.5. Russia
- 5.2.6. Netherlands
- 5.2.7. Spain
- 5.2.8. Turkey
- 5.2.9. Poland
5.3. Asia-Pacific
- 5.3.1. India
- 5.3.2. China
- 5.3.3. Japan
- 5.3.4. Australia
- 5.3.5. Vietnam
- 5.3.6. South Korea
- 5.3.7. Indonesia
- 5.3.8. Philippines
5.4. South America
- 5.4.1. Brazil
- 5.4.2. Argentina
5.5. Middle East and Africa
- 5.5.1. Saudi Arabia
- 5.5.2. UAE
- 5.5.3. South Africa

6. Market Mapping, 2023

6.1. By Product
6.2. By Application
6.3. By Size
6.4. By End-user
6.5. By Region

7. Macro Environment and Industry Structure

7.1. Demand Supply Analysis
7.2. Import Export Analysis
7.3. Value Chain Analysis
7.4. PESTEL Analysis
- 7.4.1. Political Factors
- 7.4.2. Economic System
- 7.4.3. Social Implications
- 7.4.4. Technological Advancements
- 7.4.5. Environmental Impacts
- 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
7.5. Porter's Five Forces Analysis
- 7.5.1. Supplier Power
- 7.5.2. Buyer Power
- 7.5.3. Substitution Threat
- 7.5.4. Threat From New Entrant
- 7.5.5. Competitive Rivalry

8. Market Dynamics

8.1. Growth Drivers
8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

9.1. Clinical Trials
9.2. Patent Landscape
9.3. Regulatory Approvals
9.4. Innovations/Emerging Technologies

10. Key Players Landscape

10.1. Competition Matrix of Top Five Market Leaders
10.2. Market Revenue Analysis of Top Five Market Leaders (By Value, 2023)
10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
10.4. SWOT Analysis (For Five Market Players)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

13.1. Medtronic Plc
- 13.1.1. Company Details
- 13.1.2. Key Management Personnel
- 13.1.3. Products and Services
- 13.1.4. Financials (As Reported)
- 13.1.5. Key Market Focus and Geographical Presence
- 13.1.6. Recent Developments
13.2. Penumbra Inc.
13.3. Stryker Corporation
13.4. Johnson & Johnson Services Inc.
13.5. Microport Scientific Corporation
13.6. Terumo Corporation
13.7. Acandis GmbH
13.8. NeuroVasc Technologies Inc.
13.9. Asahi Intecc USA Inc.
13.10. Integra Lifesciences Corporation

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

神経血管デバイスの世界市場の評価：製品別、用途別、サイズ別、エンドユーザー別、地域別、機会、予測、2017年～2031年

Neurovascular Devices Market Assessment, By Product, By Application, By Size, By End-user, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章世界の神経血管デバイス市場の見通し、2017年～2031年

第5章世界の神経血管デバイス市場の見通し、地域別、2017年～2031年

第6章市場マッピング、2023年

第7章マクロ環境と産業構造

第8章市場力学

第9章規制枠組みとイノベーション

第10章主要参入企業の情勢

第11章価格分析

第12章ケーススタディ

第13章主要参入企業の見通し

第14章戦略的提言

第15章お問い合わせと免責事項

List of Tables

List of Figures

Table of Contents

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Neurovascular Devices Market Outlook, 2017-2031F

5. Global Neurovascular Devices Market Outlook, By Region, 2017-2031F

6. Market Mapping, 2023

7. Macro Environment and Industry Structure

8. Market Dynamics

9. Regulatory Framework and Innovation

10. Key Players Landscape

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

14. Strategic Recommendations

15. About Us and Disclaimer

神経血管デバイスの世界市場の評価：製品別、用途別、サイズ別、エンドユーザー別、地域別、機会、予測、2017年～2031年

Neurovascular Devices Market Assessment, By Product, By Application, By Size, By End-user, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界の神経血管デバイス市場の見通し、2017年～2031年

第5章 世界の神経血管デバイス市場の見通し、地域別、2017年～2031年

第6章 市場マッピング、2023年

第7章 マクロ環境と産業構造

第8章 市場力学

第9章 規制枠組みとイノベーション

第10章 主要参入企業の情勢

第11章 価格分析

第12章 ケーススタディ

第13章 主要参入企業の見通し

第14章 戦略的提言

第15章 お問い合わせと免責事項

List of Tables

List of Figures

Table of Contents

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Neurovascular Devices Market Outlook, 2017-2031F

5. Global Neurovascular Devices Market Outlook, By Region, 2017-2031F

6. Market Mapping, 2023

7. Macro Environment and Industry Structure

8. Market Dynamics

9. Regulatory Framework and Innovation

10. Key Players Landscape

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

14. Strategic Recommendations

15. About Us and Disclaimer

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章世界の神経血管デバイス市場の見通し、2017年～2031年

第5章世界の神経血管デバイス市場の見通し、地域別、2017年～2031年

第6章市場マッピング、2023年

第7章マクロ環境と産業構造

第8章市場力学

第9章規制枠組みとイノベーション

第10章主要参入企業の情勢

第11章価格分析

第12章ケーススタディ

第13章主要参入企業の見通し

第14章戦略的提言

第15章お問い合わせと免責事項